Global Non Opioid Pain Treatment Market is expected to exhibit a CAGR of 3.9% over the forecast period 2024 to 2031. Non-opioid pain treatments include drugs that help alleviate pain without the use of opioid medications. These involve medications such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, and topical analgesics.
Global non opioid pain treatment market drugs are generally considered safer alternatives to opioid-based medications and help address the growing need to manage chronic pain without substance abuse or addiction risks. There is also a rising consumer trend favoring natural and herbal pain relief options.
Global non opioid pain treatment market is estimated to be valued at USD 78.89 billion in 2024 and is expected to reach USD 140.56 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
Key Takeaways
Key players operating in the Global Non Opioid Pain Treatment market are Acro Metal Stamping, Manor Tool Manufacturing Company, DH Industries, Inc., Kenmode, Inc., Klesk Metal Stamping Co, Clow Stamping Company, Goshen Stamping Company, Tempco Manufacturing Company, Inc, Interplex Holdings Pte. Ltd., CAPARO, Nissan Motor Co., Ltd, AAPICO Hitech Public Company Limited, Gestamp, Ford Motor Company, Arconic Corporation, American Axle Manufacturing Holdings, Inc, CIE Automotive S.A., AAPICO Hitech Public Company Limited, Wiegel Tool Works, Inc., and Boker’s, Inc. The growing awareness around adverse effects of long-term opioid use and increased government regulations are fueling the demand for non-opioid pain therapies. Technological advancements are leading to development of novel drug delivery mechanisms and combination therapies to manage both acute and chronic pain more effectively.
Market Trends
Increasing research on herbal and alternative therapies - There isrising focus on exploring herbal medicines and alternative therapies like acupuncture, massage, chiropractic treatment and yoga for chronic pain management Global Non Opioid Pain Treatment Market Size and Trends. Many clinical studies are evaluating efficacy of herbs and supplements.
Customized and personalized pain management - With better understanding of pain mechanisms, focus is shifting to more customized and personalized pain care.Biomarkers, genetics and digital tools are being utilized to develop tailored therapies for individuals.
Market Opportunities
Combination drug therapies - Combining non-opioid drugs with different mechanisms can help manage various pain typesmore effectively. Many companies are exploring fixed-dose combination products.
Emerging economies - With growing economies, expanding medical infrastructures and increasing healthcare spending, emerging countries like India, China, Brazil present major opportunities for non-opioid pain drug manufacturers.
In conclusion, the global non-opioid pain treatment market is expected to grow steadily owing to rising awareness around dangers of prolonged opioid usage and focus on developing safer and customized alternatives.
Impact of COVID-19 on Non Opioid Pain Treatment Market Growth
The COVID-19 pandemic has significantly impacted the growth of the global non opioid pain treatment market. During the initial phases of the pandemic, there was disruption in manufacturing and supply chain activities due to lockdowns imposed across various countries. This led to reduced production and shortage of non opioid pain medications. Additionally, healthcare resources and infrastructure were overburdened due to growing cases of COVID-19 infections. As a result, the focus shifted away from chronic pain treatments to management of coronavirus patients. This negatively affected the demand for non opioid painkillers.
However, with normalization of operations and gradual lifting of lockdowns, the market is recovering. Many countries have accelerated their vaccination programs to control the spread of the virus. Healthcare systems are no longer overwhelmed and are able to devote more attention to non COVID conditions. Companies are also scaling up production capacities to meet the pent up demand. Telemedicine and online pharmacies have emerged as convenient options for patients to consult doctors and obtain prescription medications without any exposure risk. The pandemic has increased awareness about minimizing usage of opioid drugs. Thus, non opioid analgesics are expected to gain preference in the coming years as part of a holistic approach for pain management.
The geographical regions where the non opioid pain treatment market is concentrated in terms of value are North America and Europe.
Asia Pacific is expected to be the fastest growing region for the global non opioid pain treatment market between 2024-2031. Rapidly advancing healthcare infrastructure, growing aging population faced with chronic pain, and increasing awareness about risks of opioid addiction are major factors fueling the demand for non opioid therapies in Asia Pacific countries like China, India, Japan and South Korea. Furthermore, large patient pool and rising healthcare expenditure provide immense growth opportunities for market players in the Asia Pacific region.
Get More Insights on- Global Non Opioid Pain Treatment Market
Discover the Report for More Insights, Tailored to Your Language:
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript">